Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 60.46% is 102% above its 5-year average of 29.91%, near the high end of its 5-year range (10.11%–60.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.31% above its 12-month average of 54.32%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 60.46%.
DEBT TO ASSETS RATIO
60.46%
DEBT TO ASSETS RATIO AVG TTM
54.32%
DEBT TO ASSETS RATIO AVG 3Y
37.83%
DEBT TO ASSETS RATIO AVG 5Y
29.91%
DEBT TO ASSETS RATIO AVG 10Y
19.45%
DEBT TO ASSETS RATIO AVG 15Y
9.46%
DEBT TO ASSETS RATIO AVG 20Y
9.23%
CURRENT VS TTM AVG
+11.31%
CURRENT VS 3Y AVG
+59.82%
CURRENT VS 5Y AVG
+102.16%
CURRENT VS 10Y AVG
+210.80%
CURRENT VS 15Y AVG
+538.81%
CURRENT VS 20Y AVG
+555.34%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+46408.81%
vs the sector median at left
Codexis, Inc.
Market Cap
$149.51M
Debt to Assets Ratio
60.46%
TTM Avg
54.32%
3Y Avg
37.83%
5Y Avg
29.91%
Market Cap
$152.16M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.45M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.84M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.49M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.11M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$162.82M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.74M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Codexis, Inc. (CDXS) | $149.51M | 60.46% | 54.32% | 37.83% | 29.91% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 0.00% | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 0.00% | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.27% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 0.20% | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | 0.00% | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | 0.06% | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | 0.36% | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | 0.02% | N/A | N/A | N/A |
Debt/Assets
60.5%
Debt/Equity
2.20
Current Ratio
3.06
Interest Coverage
-8.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 60.46% |
| 2026-03-31 | 56.35% |
| 2025-12-31 | 49.53% |
| 2025-09-30 | 55.36% |
| 2025-06-30 | 49.90% |
| 2025-03-31 | 46.16% |
| 2024-12-31 | 40.20% |
| 2024-09-30 | 28.24% |
| 2024-06-30 | 32.22% |
| 2024-03-31 | 28.89% |
| 2023-12-31 | 11.73% |
| 2023-09-30 | 12.94% |
| 2023-06-30 | 19.83% |
| 2023-03-31 | 19.41% |
| 2022-12-31 | 17.43% |
| 2022-09-30 | 19.08% |
| 2022-06-30 | 19.62% |
| 2022-03-31 | 20.10% |
| 2021-12-31 | 19.34% |
| 2021-09-30 | 10.11% |
| 2021-06-30 | 11.15% |
| 2021-03-31 | 11.46% |
| 2020-12-31 | 11.26% |
| 2020-09-30 | 18.52% |
| 2020-06-30 | 18.44% |
| 2020-03-31 | 17.49% |
| 2019-12-31 | 17.52% |
| 2019-09-30 | 18.17% |
| 2019-06-30 | 18.40% |
| 2019-03-31 | 27.16% |
| 2018-12-31 | 0.38% |
| 2018-09-30 | 0.16% |
| 2018-06-30 | 0.24% |
| 2018-03-31 | 0.55% |
| 2017-12-31 | 0.56% |
| 2017-09-30 | 0.82% |
| 2017-06-30 | 0.84% |
| 2017-03-31 | 0.83% |
| 2016-12-31 | 1.19% |
| 2016-09-30 | 2.58% |
| 2016-06-30 | 2.98% |
| 2016-03-31 | 3.07% |
| 2015-12-31 | 0.95% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 2.72% |
| 2010-06-30 | 3.74% |
| 2010-03-31 | 7.95% |
| 2009-12-31 | 8.02% |
| 2009-09-30 | 10.20% |
| 2008-12-31 | 19.30% |
| 2008-03-31 | 17.74% |
